Picture of Generation Bio logo

GBIO — Generation Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Generation Bio Reports Q3 Results

Nov 3 (Reuters) - Generation Bio Co  GBIO.O :
    * GENERATION BIO REPORTS BUSINESS HIGHLIGHTS AND THIRD
QUARTER
2022 FINANCIAL RESULTS
    * QTRLY NET LOSS WAS $31.3 MILLION, OR $0.53 BASIC AND
DILUTED NET
LOSS PER SHARE
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE
$301.2
MILLION AS OF SEPTEMBER 30, 2022
    * COMPANY BELIEVES THAT ITS CASH POSITION WILL FUND ITS
OPERATING
PLAN INTO 2025
    * Q3 EARNINGS PER SHARE VIEW $-0.67 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX4ChnPb 
Further company coverage:  GBIO.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Generation Bio

See all news